Hepatic Stellate Cell Single Cell Atlas Reveals a Highly Similar Activation Process Across Liver Disease Aetiologies

Overview

Journal JHEP Rep

Specialty Gastroenterology

Date 2025 Jan 6

PMID 39758511

Authors

Vincent Merens

Elisabeth Knetemann

Elif Gurbuz

Vincent De Smet

Nouredin Messaoudi

Hendrik Reynaert

Stefaan Verhulst

Leo A van Grunsven

Affiliations

Soon will be listed here.

Abstract

Background & Aims: The progression of chronic liver disease (CLD) is characterized by excessive extracellular matrix deposition, disrupting hepatic architecture and function. Upon liver injury, hepatic stellate cells (HSCs) differentiate towards myofibroblasts and become inflammatory, proliferative and fibrogenic. To date, it is still unclear whether HSC activation is driven by similar mechanisms in different aetiologies.

Methods: HSCs from multiple publicly available single-cell RNA-sequencing datasets were annotated and merged into a single-cell HSC activation atlas. Spheroid co-cultures of primary mouse hepatocytes/HSCs (n = 5) and ELISAs on patient plasma samples (n = 80) were performed to validate the mechanistic insight obtained from the HSC atlas.

Results: We established an HSC activation atlas in which HSCs are clearly divided into three distinct transcriptomic profiles: quiescent HSCs, initiatory HSCs and myofibroblasts. These transcriptomic profiles are present in each of the investigated mouse liver injury models as well as in human CLDs, indicating that HSC activation is a conserved process. This activation process is driven by a core set of transcription factors independent of liver injury or species. Furthermore, we reveal novel ligands associated with activation of HSCs in multiple liver injury models and validate the profibrotic effect of parathyroid hormone. Finally, we identify as a conserved marker for quiescent HSCs and a biomarker of liver fibrosis in patients with different CLDs (0.0001).

Conclusions: We reveal unexpected similarities in the regulatory mechanisms of HSCs across diverse liver injury settings and species. The HSC activation atlas has the potential to provide novel insights into liver fibrosis and steer novel treatment options.

Impact And Implications: This study establishes a single-cell atlas of hepatic stellate cells across various liver injuries, highlighting a conserved activation process between different injuries and across species. The discovery of novel activating ligands and the biomarker COLEC10 in human plasma could be used to enhance diagnostic and therapeutic strategies. Additionally, the conserved activation process supports the use of any mouse model for mechanistic studies and testing of new anti-fibrotic compounds, streamlining preclinical research efforts.

Citing Articles

Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy.

Sharip A, Kunz J Cells. 2025; 14(4).

PMID: 39996739 PMC: 11854242. DOI: 10.3390/cells14040266.

References

Urtasun R, Lopategi A, George J, Leung T, Lu Y, Wang X . Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology. 2011; 55(2):594-608. PMC: 3561739. DOI: 10.1002/hep.24701. View

Krenkel O, Hundertmark J, Ritz T, Weiskirchen R, Tacke F . Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis. Cells. 2019; 8(5). PMC: 6562512. DOI: 10.3390/cells8050503. View

Jaroenlapnopparat A, Rittiphairoj T, Chaisidhivej N, Walker B, Charoenngam N . High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023; 17(8):102827. DOI: 10.1016/j.dsx.2023.102827. View

Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M . Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021; 39(6):866-882.e11. PMC: 8241235. DOI: 10.1016/j.ccell.2021.03.012. View

Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S . A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020; 15(7):2247-2276. DOI: 10.1038/s41596-020-0336-2. View

Bahr M, Vincent K, Arthur M, Fowler A, Smart D, Wright M . Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology. 1999; 29(3):839-48. DOI: 10.1002/hep.510290333. View

Fred R, Pedersen J, Thompson J, Lee J, Timshel P, Stender S . Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. Sci Rep. 2022; 12(1):13484. PMC: 9355943. DOI: 10.1038/s41598-022-16754-7. View

Filliol A, Saito Y, Nair A, Dapito D, Yu L, Ravichandra A . Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022; 610(7931):356-365. PMC: 9949942. DOI: 10.1038/s41586-022-05289-6. View

Rosenthal S, Liu X, Ganguly S, Dhar D, Pasillas M, Ricciardelli E . Heterogeneity of HSCs in a Mouse Model of NASH. Hepatology. 2021; 74(2):667-685. PMC: 8346581. DOI: 10.1002/hep.31743. View

10.

Pu S, Zhou H, Liu Y, Liu J, Guo Y, Zhou H . Roles of nuclear receptors in hepatic stellate cells. Expert Rev Gastroenterol Hepatol. 2021; 15(8):879-890. DOI: 10.1080/17474124.2021.1949288. View

11.

Leite S, Roosens T, El Taghdouini A, Mannaerts I, Smout A, Najimi M . Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro. Biomaterials. 2015; 78:1-10. DOI: 10.1016/j.biomaterials.2015.11.026. View

12.

Flood H, Bolte C, Dasgupta N, Sharma A, Zhang Y, Gandhi C . The Forkhead box F1 transcription factor inhibits collagen deposition and accumulation of myofibroblasts during liver fibrosis. Biol Open. 2019; 8(2). PMC: 6398469. DOI: 10.1242/bio.039800. View

13.

Mederacke I, Hsu C, Troeger J, Huebener P, Mu X, Dapito D . Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013; 4:2823. PMC: 4059406. DOI: 10.1038/ncomms3823. View

14.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

15.

Liu C, Chen X, Yang L, Kisseleva T, Brenner D, Seki E . Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells. J Biol Chem. 2014; 289(10):7082-7091. PMC: 3945368. DOI: 10.1074/jbc.M113.543769. View

16.

Kolodziejczyk A, Federici S, Zmora N, Mohapatra G, Dori-Bachash M, Hornstein S . Acute liver failure is regulated by MYC- and microbiome-dependent programs. Nat Med. 2020; 26(12):1899-1911. DOI: 10.1038/s41591-020-1102-2. View

17.

Ratziu V, Sanyal A, Loomba R, Rinella M, Harrison S, Anstee Q . REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis. Contemp Clin Trials. 2019; 84:105803. DOI: 10.1016/j.cct.2019.06.017. View

18.

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

19.

Browaeys R, Saelens W, Saeys Y . NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2019; 17(2):159-162. DOI: 10.1038/s41592-019-0667-5. View

20.

Yang W, He H, Wang T, Su N, Zhang F, Jiang K . Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology. 2021; 74(5):2774-2790. PMC: 8597108. DOI: 10.1002/hep.31987. View